TMCnet News
Global Non-Structural Protein 4A Inhibitors Pipeline Insights Report 2017 - Research and MarketsResearch and Markets has announced the addition of the "Non-Structural Protein 4A Inhibitors - Pipeline Insights, 2017" report to their offering. Non-Structural Protein 4A Inhibitors - Pipeline Insights, 2017 provides in depth insights on the pipeline drugs and their development activities around the Non-Structural Protein 4A Inhibitors. The This report covers the product profiles in various stages of development including Discovery, Pre - clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details. This report also provides detailed information on the discontinued and dormant drugs that have one inactive over the years for Non-Structural Protein 4A Inhibitors. This report also assesses the Non-Structural Protein 4A Inhibitors therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/3qtnj3/nonstructural
View source version on businesswire.com: http://www.businesswire.com/news/home/20170123005696/en/ |